WO2007005715A3 - Staphylococcal antibodies which cross-react with fungal antigens - Google Patents
Staphylococcal antibodies which cross-react with fungal antigens Download PDFInfo
- Publication number
- WO2007005715A3 WO2007005715A3 PCT/US2006/025782 US2006025782W WO2007005715A3 WO 2007005715 A3 WO2007005715 A3 WO 2007005715A3 US 2006025782 W US2006025782 W US 2006025782W WO 2007005715 A3 WO2007005715 A3 WO 2007005715A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cross
- antibodies
- react
- fungal antigens
- staphylococcal antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Abstract
Cross-reactive antibodies are provided which can recognize antigens from Staphylococcus epidermidis such as the SdrG protein and from Candida albicans, such the Hsp70 protein. These antibodies will thus be useful in methods of treating or preventing infections from Staphylococcus and Candida microorganisms at the same time. Compositions and kits containing these antibodies as well as methods for their use are also provided.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69544105P | 2005-07-01 | 2005-07-01 | |
US60/695,441 | 2005-07-01 | ||
US77287106P | 2006-02-14 | 2006-02-14 | |
US60/772,871 | 2006-02-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007005715A2 WO2007005715A2 (en) | 2007-01-11 |
WO2007005715A3 true WO2007005715A3 (en) | 2009-04-16 |
Family
ID=37605080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/025782 WO2007005715A2 (en) | 2005-07-01 | 2006-07-03 | Staphylococcal antibodies which cross-react with fungal antigens |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007005715A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699677B1 (en) * | 1999-12-20 | 2004-03-02 | Chemocentryx, Inc. | Tethered ligands and methods of use |
-
2006
- 2006-07-03 WO PCT/US2006/025782 patent/WO2007005715A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699677B1 (en) * | 1999-12-20 | 2004-03-02 | Chemocentryx, Inc. | Tethered ligands and methods of use |
Also Published As
Publication number | Publication date |
---|---|
WO2007005715A2 (en) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008022295A3 (en) | Prlr-specific antibody and uses thereof | |
WO2005027966A3 (en) | Antibodies with altered effector functions | |
WO2005068503A3 (en) | M-csf-specific monoclonal antibody and uses thereof | |
WO2005097832A3 (en) | Humanized anti-tgf-beta antibodies | |
WO2001098317A3 (en) | Alpha-glycosylceramides for treating bacterial and fungal infections | |
WO2006104989A3 (en) | Altered antibody fc regions and uses thereof | |
WO2008070344A3 (en) | Compositions and methods for binding sphingosine-1-phosphate | |
WO2007120656A3 (en) | Uses and compositions for treatment of rheumatoid arthritis | |
WO2008069889A3 (en) | Methods of treating hemolytic anemia | |
WO2013025834A3 (en) | Compositions and methods related to antibodies to staphylococcal protein a | |
EP2620450A3 (en) | Anti-CTLA-4 antibody compositions | |
WO2006133164A3 (en) | Anti-trkb monoclonal antibodies and uses thereof | |
WO2007058823A3 (en) | Anti-egfr antibodies | |
EP2311876A3 (en) | M-CSF-specific monoclonal antibody and uses thereof | |
EP2289938A3 (en) | Use of Panton-Valentine Leukocidin for treating and preventing staphylococcus infections | |
WO2017136659A3 (en) | Humanized anti-cd3 antibodies, conjugates and uses thereof | |
WO2007059226A3 (en) | Photoactivatable antimicrobial agents | |
IL213523A0 (en) | Compositions comprising blood group antigens | |
WO2006138627A3 (en) | Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein | |
WO2007126813A3 (en) | Cross-reactive monoclonal antibodies recognizing als family proteins | |
WO2009137677A3 (en) | Reagents, methods, and systems for detecting methicillin-resistant staphylococcus | |
WO2006097233A3 (en) | Determination of antibiotic resistance in staphylococcus aureus | |
WO2018069871A3 (en) | Anti-kras binding proteins | |
WO2008019326A3 (en) | Ephb3-specific antibody and uses thereof | |
CL2007003693A1 (en) | COMPOUNDS DERIVED FROM PIRIDO [3,2-B] [1,4] THIAZINE; PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF BACTERIAL INFECTIONS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06786091 Country of ref document: EP Kind code of ref document: A2 |